Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

ExpreS2ion Biotech Holding

5.05 SEK

-4.72 %

Less than 1K followers

EXPRS2

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding

EV/S

Median 2019-2022

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)111.29337.851,139.38525.4872.1320.6015.90
Shares0.50.50.91.11.52.73.5
Market cap52.8173.61,074.9580.1108.554.856.1
Enterprise value53.968.7937.9470.9---
EV/S3.94.576.792.5---
EV/EBITDAneg.neg.neg.neg.---
EV/EBITneg.neg.neg.neg.---
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B-48.911.847.665.611.780.851.57
P/S3.811.487.9114.015.418.215.3
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio-5.8 %79.6 %92.4 %75.2 %82.0 %61.6 %54.8 %
Gearing ratio-601.8 %2.0 %1.4 %1.7 %0.5 %0.6 %1.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.